MAPT and Alzheimer disease: When comparing the AD pathologies of the iNPH patients in our study population, we found that the levels of LRG are equal between the studied groups while the levels of Aβ1-42, T-tau, and P-tau181 are useful in separating the iNPH patients with AD-related pathology from those with no AD-related pathology.